Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Diabetes Technol Ther ; 17(8): 548-54, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25961446

ABSTRACT

OBJECTIVE: Accuracy of continuous glucose monitoring (CGM) devices in hypoglycemia has been a widely reported shortcoming of this technology. We report the accuracy in hypoglycemia of a new version of the Dexcom (San Diego, CA) G4 Platinum CGM system (software 505) and present results regarding the optimum setting of CGM hypoglycemic alerts. MATERIALS AND METHODS: CGM values were compared with YSI analyzer (YSI Life Sciences, Yellow Springs, OH) measurements every 15 min. We reviewed the accuracy of the CGM system in the hypoglycemic range using standard metrics. We analyzed the time required for the CGM system to detect biochemical hypoglycemia (70 mg/dL) compared with the YSI with alert settings at 70 mg/dL and 80 mg/dL. We also analyzed the time between the YSI value crossing 55 mg/dL, defined as the threshold for cognitive impairment due to hypoglycemia, and when the CGM system alerted for hypoglycemia. RESULTS: The mean absolute difference for a glucose level of less than 70 mg/dL was 6 mg/dL. Ninety-six percent of CGM values were within 20 mg/dL of the YSI values between 40 and 80 mg/dL. When the CGM hypoglycemic alert was set at 80 mg/dL, the device provided an alert for biochemical hypoglycemia within 10 min in 95% of instances and at least a 10-min advance warning before the cognitive impairment threshold in 91% of instances in the study. CONCLUSIONS: Use of an 80 mg/dL threshold setting for hypoglycemic alerts on the G4 Platinum (software 505) may provide patients with timely warning of hypoglycemia before the onset of cognitive impairment, enabling them to treat themselves for hypoglycemia with fast-acting carbohydrates and prevent neuroglycopenia associated with very low glucose levels.


Subject(s)
Blood Glucose Self-Monitoring/instrumentation , Blood Glucose/analysis , Diabetes Mellitus, Type 1/drug therapy , Hypoglycemia/prevention & control , Insulin Infusion Systems/statistics & numerical data , Adult , Aged , Algorithms , Blood Glucose Self-Monitoring/methods , Cognition Disorders/chemically induced , Cognition Disorders/prevention & control , Diabetes Mellitus, Type 1/blood , Female , Humans , Hypoglycemia/chemically induced , Hypoglycemic Agents/administration & dosage , Insulin/administration & dosage , Male , Middle Aged , Prospective Studies , Reference Values , Reproducibility of Results , Software , Time Factors , Young Adult
2.
Infect Control Hosp Epidemiol ; 31(4): 382-7, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20175682

ABSTRACT

OBJECTIVE: To characterize the temporal progression of the monthly incidence of Clostridium difficile infections (CDIs) and to determine whether the incidence of CDI is related to the incidence of seasonal influenza. DESIGN: A retrospective study of patients in the Nationwide Inpatient Sample during the period from 1998 through 2005. METHODS: We identified all hospitalizations with a primary or secondary diagnosis of CDI with use of International Classification of Diseases, 9th Revision, Clinical Modification codes, and we did the same for influenza. The incidence of CDI was modeled as an autoregression about a linear trend. To investigate the association of CDI with influenza, we compared national and regional CDI and influenza series data and calculated cross-correlation functions with data that had been prewhitened (filtered to remove temporal patterns common to both series). To estimate the burden of seasonal CDI, we developed a proportional measure of seasonal CDI. RESULTS: Time-series analysis of the monthly number of CDI cases reveals a distinct positive linear trend and a clear pattern of seasonal variation (R2 = 0.98). The cross-correlation functions indicate that influenza activity precedes CDI activity on both a national and regional basis. The average burden of seasonal (ie, winter) CDI is 23%. CONCLUSIONS: The epidemiologic characteristics of CDI follow a pattern that is seasonal and associated with influenza, which is likely due to antimicrobial use during influenza seasons. Approximately 23% of average monthly CDI during the peak 3 winter months could be eliminated if CDI remained at summer levels.


Subject(s)
Clostridioides difficile , Enterocolitis, Pseudomembranous/epidemiology , Influenza, Human/epidemiology , Seasons , Enterocolitis, Pseudomembranous/complications , Enterocolitis, Pseudomembranous/diagnosis , Enterocolitis, Pseudomembranous/microbiology , Hospitalization/statistics & numerical data , Humans , Incidence , Influenza, Human/complications , International Classification of Diseases , Time Factors , United States/epidemiology
3.
Clin Infect Dis ; 46(9): 1447-9, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18419451

ABSTRACT

To determine how long people shed virus after the onset of mumps, we used logistic regression modeling to analyze data from the 2006 outbreak of mumps in Iowa. Our model establishes that the probability of mumps virus shedding decreases rapidly after the onset of symptoms. However, we estimate that 8%-15% of patients will still be shedding the virus 5 days after the onset of symptoms and, thus, may still be contagious during this period.


Subject(s)
Mumps virus/physiology , Mumps/virology , Virus Shedding , Disease Outbreaks , Humans , Iowa/epidemiology , Logistic Models , Models, Statistical , Mumps/epidemiology , Mumps/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...